Mainland animal lab poses risks: GAO

The US Department of Homeland Security (DHS) has not demonstrated that moving foot-and-mouth disease (FMD) research from an island lab in New York to a linkurl:new mainland animal research facility;http://www.the-scientist.com/news/display/23091/ would be safe, the Government Accountability Office (GAO) told a Congressional committee this morning (May 22). "We found that linkurl:DHS;http://www.the-scientist.com/blog/display/54186/ has not conducted or commissioned any study" to assess whether

Written byAlla Katsnelson
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
The US Department of Homeland Security (DHS) has not demonstrated that moving foot-and-mouth disease (FMD) research from an island lab in New York to a linkurl:new mainland animal research facility;http://www.the-scientist.com/news/display/23091/ would be safe, the Government Accountability Office (GAO) told a Congressional committee this morning (May 22). "We found that linkurl:DHS;http://www.the-scientist.com/blog/display/54186/ has not conducted or commissioned any study" to assess whether FMD can be safely researched on the mainland, Nancy Kingsbury, managing director of applied research and methods at the GOA, told the committee. Instead, she said, the agency based its decision on a 2002 study conducted by the USDA that examined technical feasibility, not safety. "That's a very different question," she said. The FMD virus is one of the most contagious of all animal diseases, and since 1955 research on the pathogen has been conducted exclusively in a lab on Plum Island, about three miles off the coast of Long Island, NY. The Plum Island lab is linkurl:in dire need of renovations,;http://www.the-scientist.com/news/display/23731/ however, and the government has proposed relocating FMD research to a new National Bio and Agro-Defense Facility to be built on the mainland, which would house the largest high-security biocontainment facility in the world. So far, five finalist sites have been proposed for the facility: Athens, Ga.; Manhattan, Kan.; Butner, NC.; Flora, Miss., and San Antonio, TX. The plan has been greeted with controversy, with opponents saying that an FMD leak -- such as occurred in the UK in 2001 and linkurl:2007;http://www.the-scientist.com/blog/display/54423/ -- so close to US farms and ranches could wreak economic havoc, and cost the country as much as $40 billion. Congressman John Dingell (D-Mich), a member of the committee, noted at the hearing that the 2002 report on which DHS based its assertion that a mainland facility would be safe in fact supported renovating the Plum Island lab rather than moving FMD research to a new facility. The GAO also said that DHS has refused to turn over risk assessment documents that have been commissioned for the Plum Island research facility, and the five mainland sites under consideration for the new facility -- making a true assessment of safety impossible. According to the GAO, an accidental release occurred at Plum Island in 1978, but the virus didn't spread thanks to the lab's island location. New FMD research facilities recently built in Germany and Denmark have been sequestered islands for safety reasons as well, Kinsgbury told the committee. But Congressman Chip Pickering (R-Miss) argued that a land-based facility would indeed be safe. He said the protection offered by a 3-6 mile distance from the mainland was illusory, since winds could easily carry the virus such a distance to the mainland.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform